References
1. A. Désiré et al., Pharm. Technol.
35 (1), 56–65 (2011).
2. C. Lustig-Gustafsson et al., Eur. J. Pharm. Sci.
8 (2), 147–152 (1999).
3. G. Tomer, F.Podczeck, and J.M. Newton, Int. J. Pharm.
217 (1–2), 237–248 (2001).
4. G. Tomer, F. Podczeck, and J.M. Newton, Int. J. Pharm.
231 (1), 248–257 (2002).
5. J.J. Sousa et al., Int. J. Pharm.
232 (1–2), 91–106 (2002).
6. J. Chatchawalsaisin, F. Podczeck, and J.M. Newton, Eur J Pharm Sci.
24 (1), 35–48 (2005).
7. D. Lutchman, C.M. Dangor, and D. Perumal, J. Microencapsul.
22 (6), 643–659 (2005).
8. F.O. Costa, A.A.C.C. Pais, and J.J.S., Int. J. Pharm.
270 (1–2), 9–19 (2004).
9. G.A. Hileman et al., Int. J. Pharm.
100 (1–3), 71–79 (1993).
10. L. Baert and G.R.B. Down, Int. J. Pharm.
107 (3), 219–222 (1994).
11. L. Alvarez et al., Eur. J. Pharm. Biopharm. 55 (3), 291–295 (2003).
12. R. Gandhi et al., Pharm. Technol.
29 (2). 68–86 (2005).
13. L. Rahman et al., STP Pharm. Sci.
1 (5), 294–299 (1991).
14. E. Nürnberg, and J. Wunderlich, Pharm. Technol. Eur.
11 (3), 30-34 (1999).
15. S. Galland, T. Ruiz, and M. Delalonde, Int. J. Pharm.
337 (1–2), 239–245 (2007).
16. S. Galland, T. Ruiz, and M. Delalonde, Powder Technol.
190 (1–2), 48–52 (2009).
17. J.F. Pinto and C.N. Abreu, Drug. Dev. Ind. Pharm.
32 (9), 1067–1078 (2006).
18. L. Hellén, J. Yliruusi, and E. Kristoffersson, Int. J. Pharm.
96 (1–3), 197–204 (1993).
19. L. Hellén, J. Yliruusi, and E. Kristoffersson, Int. J. Pharm.
96 (1–3), 205–216 (1993).
20. L. Hellén, J. Yliruusi, and E. Kristoffersson, Int. J. Pharm.
96 (1–3), 217–223 (1993).
21. A.M. Juppo et al., Eur. J. Pharm. Biopharm. 44 (2), 205–214 (1997).
22. V.R. Sinha et al., AAPSPharmSciTech,
8 (1), E1–E5 (2007).
23. S. Galland et al., Powder Technol.
157 (1–3), 156–162 (2005).
24. D. Sonaglio et al., Int. J. Pharm.
115 (1), 53–60 (1995).
25. E.I. Hamedelniel, J.Bajdik, and K.Pintye-Hódi, Chemical Engineering and Processing: Process Intensification
49 (1), 120–124 (2010).
26. A. Häring, K. Krejcova, and M. Rabiskova, Farm. Vestn.
54 (special issue), 437–438 (2003).
27. L. Baert et al., Int. J. Pharm.
86 (2–3), 187–192 (1992).
28. L. Baert et al., Int. J. Pharm.
99 (1), 7–12. (1993).
29. C. Schmidt, H. Lindner, and P. Kleinebudde, Eur. J. Pharm. Biopharm. 44 (2), 169–176 (1997).
30. K. Thoma and I. Ziegler, Drug Dev. Ind. Pharm. 24 (5), 401–411 (1998).
31. K. Thoma, and I. Ziegler, Drug Dev. Ind. Pharm. 24 (5), 413–422 (1998).
32. D. Sonaglio, B. Bataille, and M. Jacob, Pharm. Acta Helv.
72 (2), 69–74 (1997).
33. C. Schmidt, and P. Kleinebudde, Eur. J. Pharm. Biopharm. 45 (2), 173–179 (1998).
34. J.M. Newton, S.R. Chapman, and R.C. Rowe, Int. J. Pharm.
120 (1), 101–109 (1995).
35. D. Sonaglio et al., Pharmazie
52 (2), 129–134 (1997).
36. P. Costa and J.M. Sousa Lobo, Eur. J. Pharm. Sci.
13 (2), 123–133 (2001).
37. E. Jerwanska et al., Int. J. Pharm.
121 (1), 65–71 (1995).
38. P. Kleinebudde and H. Lindner, Int. J. Pharm.
94 (1–3), 49–58 (1993).
39. A.B. Bashaiwoldu, F. Podczeck and J.M. Newton, Eur. J. Pharm. Sci. 21 (2–3), 119–129 (2004).
40. B. Song, S.L. Rough, and D.I. Wilson, Int. J. Pharm.
332 (1–2), 38–44 (2007).
41. J.P. Perez and M. Rabiskova, Int. J. Pharm.
242 (1–2), 349–351 (2002).
42. J.J. Sousa et al., Int. J. Pharm.
144 (2), 159–169 (1996).
43. J. Berggren and G. Alderborn, Int. J. Pharm.
219 (1–2), 113–126 (2001).
44. P. Kleinebudde, Int. J. Pharm.
109 (3), 209–219 (1994).
45. P. Kleinebudde, Int. J. Pharm.
109 (3), 221–227 (1994).
46. B. Bataille, K. Ligarski, and M. Jacob, Pharm. Acta Helv.
65 (12), 334–337 (1990).
47. K. Ligarski et al., STP Pharma Sci.
1 (4), 256–261 (1991).
48. B. Bataille et al., Drug Dev. Ind. Pharm. 19 (6), 653–671 (1993).
49. K. Umprayn, P. Chitropas, and S. Amarekajorn, Drug Dev. Ind. Pharm. 25 (1), 45–61 (1999).
Citation: When referring to this article, please cite it as "Amelie Desire, Bruno Paillard, Joel Bougaret, Michel Baron, Guy
Couarraze, "A Comparison of Three Extrusion Systems (Part II)," Pharmaceutical Technology 35 (6) 56-61(2011)."
|
